(Q39593488)

13 September 2017

1 reference

title

Potential therapeutic indications for growth hormone and growth hormone-releasing hormone in conditions other than growth retardation (English)

1 reference

13 September 2017

main subject

therapeutic indication

1 reference

Williams TC

1

1 reference

13 September 2017

Frohman LA

series ordinal

2

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 November 1986

1 reference

13 September 2017

1 reference

13 September 2017

volume

6

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

311-318

1 reference

Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Human Growth Hormone: Complementary DNA Cloning and Expression in Bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

The use of growth hormone-releasing hormone in the diagnosis and treatment of short stature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Acceleration of growth in two children treated with human growth hormone-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Growth hormone-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

6 Factors controlling blood concentration of somatomedin C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Effect of growth hormone on vitamin D metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Activation of renal 1,25-dihydroxyvitamin D3 synthesis by phosphate deprivation: evidence for a role for growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Effects of Growth Hormone Replacement Therapy on 1,25-Dihydroxyvitamin D and Calcium Metabolism*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Growth hormone: the effect on skeletal renewal in the adult dog. II. Mineral kinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Growth hormone: the effect on skeletal renewal in the adult dog. I. Morphometric studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Effects of growth hormone in osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Combination therapy for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Treatment of osteoporosis with calcitonin, with and without growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Some effects of human growth hormone on renal hemodynamics and on tubular phosphate transport in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Kidney function and size in normal subjects before and during growth hormone administration for one week

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Kidney function and size in type 1 (insulin-dependent) diabetic patients before and during growth hormone administration for one week

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Body composition in hypopituitary dwarfs before and during human growth hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Growth hormone response in the thinned obese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Endocrine function in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Evidence for marked sensitivity to the antilipolytic action of insulin in obese maturity-onset diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

The antilipolytic effect of insulin in human adipose tissue in obesity, diabetes mellitus, hyperinsulinemia, and starvation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Dependence of hypothalamic obesity on insulin, the pituitary and the adrenal gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

LIPOLYTIC EFFECTS OF HUMAN GROWTH HORMONE IN RESISTANT OBESITY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Influence of norepinephrine, growth hormone and fasting on FFA mobilization and glucose metabolism in lean and obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Late Appearance of Hyperlipemia in Hypopituitarism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Diabetes mellitus and sexual ateliotic dwarfism: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Studies of hyperlipidemia in the HGH-deficient state

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Vascular disease in the chronic HGH-deficient state

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Serum cholesterol and triglycerides in children with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Familial combined hyperlipoproteinemia. Evidence for a role of growth hormone deficiency in effecting its manifestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

The effect of growth hormone on hematopoiesis in hypophysectomized adult female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Observations on the responsiveness of human subjects to human growth hormone. Effects of endogenous growth hormone deficiency and myotinic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Relation between growth hormone levels and Von Willebrand factor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Impaired growth hormone secretion in the adult population: relation to age and adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Responses of growth hormone (GH) and somatomedin-C to GH-releasing hormone in healthy aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Growth hormone, body composition, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

Pituitary Growth Hormone Essential for Regulation of Serum Cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1986.TB03493.X

10.1002/J.1875-9114.1986.TB03493.X

21 January 2018

Identifiers

DOI

1 reference

release_2aruqilbjjcirfp4u5s7ejvnh4

13 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2aruqilbjjcirfp4u5s7ejvnh4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference